Literature DB >> 30527631

The influence of interferon on healthy and diseased skin.

Grace A Hile1, Johann E Gudjonsson2, J Michelle Kahlenberg3.   

Abstract

Type I interferons (IFNs) are an immunomodulatory class of cytokines that serve to protect against viral and bacterial infection. In addition, mounting evidence suggests IFNs, particularly type I but also IFNγ, are important to the pathogenesis of autoimmune and inflammatory skin diseases, such as cutaneous lupus erythematosus (CLE). Understanding the role of IFNs is relevant to anti-viral responses in the skin, skin biology, and therapeutics for these IFN-related conditions. Type I IFNs (α and β) are produced by recruited inflammatory cells and by the epidermis itself (IFNκ) and have important roles in autoimmune and inflammatory skin disease. Here, we review the current literature utilizing a PubMed database search using terms [interferon/IFN/type I IFN AND lupus/ cutaneous lupus/CLE/dermatomyositis/Sjogrens/psoriasis/lichen planus/morphea/alopecia areata/vitiligo] with a focus on the role of IFNs in basic keratinocyte biology and their implications in the cutaneous autoimmune and inflammatory diseases: cutaneous lupus erythematosus, dermatomyositis, Sjogren's syndrome, psoriasis, lichen planus, alopecia areata and vitiligo. We provide information about genes and proteins induced by IFNs and how downstream mechanisms relate to clinical disease.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmune; Dermatology; Inflammation; Keratinocyte; Type I interferon

Mesh:

Substances:

Year:  2018        PMID: 30527631      PMCID: PMC6551332          DOI: 10.1016/j.cyto.2018.11.022

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  120 in total

Review 1.  Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases.

Authors:  M Afshar; A D Martinez; R L Gallo; T R Hata
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-06-01       Impact factor: 6.166

2.  Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis.

Authors:  Ronan J Walsh; Sek Won Kong; Yihong Yao; Bahija Jallal; Peter A Kiener; Jack L Pinkus; Alan H Beggs; Anthony A Amato; Steven A Greenberg
Journal:  Arthritis Rheum       Date:  2007-11

3.  Targeting the IFN-γ/CXCL10 pathway in lichen planus.

Authors:  Vito Di Lernia
Journal:  Med Hypotheses       Date:  2016-04-25       Impact factor: 1.538

4.  Familial Aicardi-Goutières syndrome due to SAMHD1 mutations is associated with chronic arthropathy and contractures.

Authors:  Russell C Dale; Hannah Gornall; Davinder Singh-Grewal; Melanie Alcausin; Gillian I Rice; Yanick J Crow
Journal:  Am J Med Genet A       Date:  2010-04       Impact factor: 2.802

5.  Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus.

Authors:  Stephan Meller; Franziska Winterberg; Michel Gilliet; Anja Müller; Ingrida Lauceviciute; Juliane Rieker; Norbert J Neumann; Robert Kubitza; Michael Gombert; Erich Bünemann; Ulrike Wiesner; Petra Franken-Kunkel; Holger Kanzler; Marie-Caroline Dieu-Nosjean; Ali Amara; Thomas Ruzicka; Percy Lehmann; Albert Zlotnik; Bernhard Homey
Journal:  Arthritis Rheum       Date:  2005-05

6.  Ultraviolet B Irradiation Causes Stimulator of Interferon Genes-Dependent Production of Protective Type I Interferon in Mouse Skin by Recruited Inflammatory Monocytes.

Authors:  Clayton Sontheimer; Denny Liggitt; Keith B Elkon
Journal:  Arthritis Rheumatol       Date:  2017-04       Impact factor: 10.995

7.  CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.

Authors:  Mehdi Rashighi; Priti Agarwal; Jillian M Richmond; Tajie H Harris; Karen Dresser; Ming-Wan Su; Youwen Zhou; April Deng; Christopher A Hunter; Andrew D Luster; John E Harris
Journal:  Sci Transl Med       Date:  2014-02-12       Impact factor: 17.956

8.  Interferon alpha-inducible protein 27 (IFI27) is upregulated in psoriatic skin and certain epithelial cancers.

Authors:  Sari Suomela; Li Cao; Anne Bowcock; Ulpu Saarialho-Kere
Journal:  J Invest Dermatol       Date:  2004-03       Impact factor: 8.551

9.  A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus.

Authors:  Min Ae Lee-Kirsch; Dipanjan Chowdhury; Scott Harvey; Maoliang Gong; Lydia Senenko; Kerstin Engel; Christiane Pfeiffer; Thomas Hollis; Manfred Gahr; Fred W Perrino; Judy Lieberman; Norbert Hubner
Journal:  J Mol Med (Berl)       Date:  2007-04-18       Impact factor: 5.606

10.  Molecular signatures define alopecia areata subtypes and transcriptional biomarkers.

Authors:  Ali Jabbari; Jane E Cerise; James C Chen; Julian Mackay-Wiggan; Madeleine Duvic; Vera Price; Maria Hordinsky; David Norris; Raphael Clynes; Angela M Christiano
Journal:  EBioMedicine       Date:  2016-03-31       Impact factor: 8.143

View more
  5 in total

1.  Paradoxical psoriasis induced by TNF-α blockade shows immunological features typical of the early phase of psoriasis development.

Authors:  Luca Fania; Martina Morelli; Claudia Scarponi; Laura Mercurio; Fernanda Scopelliti; Caterina Cattani; Giovanni Luca Scaglione; Tiziano Tonanzi; Maria Antonietta Pilla; Gianluca Pagnanelli; Cinzia Mazzanti; Giampiero Girolomoni; Andrea Cavani; Stefania Madonna; Cristina Albanesi
Journal:  J Pathol Clin Res       Date:  2019-10-29

2.  On the Nose: Anti-MDA-5 Dermatomyositis Manifesting as Perinasal Swelling.

Authors:  Emily Molina; Lisa Christopher-Stine; Jemima Albayda
Journal:  Case Rep Dermatol       Date:  2022-01-10

Review 3.  The Role of Cutaneous Type I IFNs in Autoimmune and Autoinflammatory Diseases.

Authors:  Jessica L Turnier; J Michelle Kahlenberg
Journal:  J Immunol       Date:  2020-12-01       Impact factor: 5.422

Review 4.  Cutaneous Lupus Erythematosus: Current and Future Pathogenesis-Directed Therapies.

Authors:  Alicia J Little; Matthew D Vesely
Journal:  Yale J Biol Med       Date:  2020-03-27

5.  Type I interferon.

Authors:  Timothy B Niewold
Journal:  Cytokine       Date:  2020-04-22       Impact factor: 3.861

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.